Authors:
Messele, T
De Wit, TFR
Brouwer, M
Aklilu, M
Birru, T
Fontanet, AL
Schuitemaker, H
Hamann, D
Citation: T. Messele et al., No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative ethiopian commercial sex workers and low-risk control subjects, AIDS RES H, 17(5), 2001, pp. 433-441
Authors:
Van Praag, RME
Prins, JM
Roos, MTL
Schellekens, PTA
Ten Berge, IJM
Yong, SL
Schuitemaker, H
Eerenberg, AJM
Jurriaans, S
De Wolf, F
Fox, CH
Goudsmit, J
Miedema, F
Lange, JMA
Citation: Rme. Van Praag et al., OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion, J CLIN IMM, 21(3), 2001, pp. 218-226
Authors:
Beaumont, T
van Nuenen, A
Broersen, S
Blattner, WA
Lukashov, VV
Schuitemaker, H
Citation: T. Beaumont et al., Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course, J VIROLOGY, 75(5), 2001, pp. 2246-2252
Authors:
Kwa, D
Vingerhoed, J
Boeser-Nunnink, B
Broersen, S
Schuitemaker, H
Citation: D. Kwa et al., Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)T-cell subsets are determined only by coreceptor expression, J VIROLOGY, 75(21), 2001, pp. 10455-10459
Authors:
Kreisberg, JF
Kwa, D
Schramm, B
Trautner, V
Connor, R
Schuitemaker, H
Mullins, JI
van't Wout, AB
Goldsmith, MA
Citation: Jf. Kreisberg et al., Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status, J VIROLOGY, 75(18), 2001, pp. 8842-8847
Citation: Fa. Koning et al., No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1, J VIROLOGY, 75(18), 2001, pp. 8848-8853
Authors:
Maas, JJJ
Gange, SJ
Schuitemaker, H
Coutinho, RA
van Leeuwen, R
Margolick, JB
Citation: Jjj. Maas et al., Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study, AIDS, 14(9), 2000, pp. 1155-1161
Authors:
Kostense, S
Krop, E
Blaak, H
Schuitemaker, H
Miedema, F
Citation: S. Kostense et al., Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducing HIV-1 variants, AIDS, 14(3), 2000, pp. 330-331
Authors:
Putter, H
Prins, JM
Jurriaans, S
Roos, M
Ferguson, NM
van Praag, R
van der Hoek, L
Schuitemaker, H
Anderson, RM
Goudsmit, J
Lange, JMA
de Wolf, F
Citation: H. Putter et al., Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection, AIDS, 14(18), 2000, pp. 2831-2839
Authors:
Reijers, MHE
Weigel, HM
Hart, AAM
Ten Kate, RW
Mulder, JW
Reiss, P
Schuitemaker, H
Hoetelmans, RMW
Weverling, GJ
Lange, JMA
Citation: Mhe. Reijers et al., Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study, AIDS, 14(1), 2000, pp. 59-68
Authors:
Blaak, H
Ran, LJ
Rientsma, R
Schuitemaker, H
Citation: H. Blaak et al., Susceptibility of in vitro stimulated PBMC to infection with NSIHIV-1 is associated with levels of CCR5 expression and beta-chemokine production, VIROLOGY, 267(2), 2000, pp. 237-246
Authors:
Blaak, H
van't Wout, AB
Brouwer, M
Hooibrink, B
Hovenkamp, E
Schuitemaker, H
Citation: H. Blaak et al., In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline, P NAS US, 97(3), 2000, pp. 1269-1274
Authors:
Scoggins, RM
Taylor, JR
Patrie, J
van't Wout, AB
Schuitemaker, H
Camerini, D
Citation: Rm. Scoggins et al., Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice, J VIROLOGY, 74(7), 2000, pp. 3205-3216
Citation: Na. Kootstra et al., Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of thecell cycle, J VIROLOGY, 74(4), 2000, pp. 1712-1717
Authors:
Beaumont, T
Broersen, S
van Nuenen, AD
Huisman, HG
Husman, AMD
Heeney, JL
Schuitemaker, H
Citation: T. Beaumont et al., Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees, J VIROLOGY, 74(17), 2000, pp. 7699-7707
Authors:
van Rij, RP
Blaak, H
Visser, JA
Brouwer, M
Rientsma, R
Broersen, S
Husman, AMD
Schuitemaker, H
Citation: Rp. Van Rij et al., Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1, J CLIN INV, 106(8), 2000, pp. 1039-1052
Authors:
van Rij, RP
Blaak, H
Visser, JA
Brouwer, M
Rientsma, R
Broersen, S
Husman, AMD
Schuitemaker, H
Citation: Rp. Van Rij et al., Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1 (vol 106, pg 1039, 2000), J CLIN INV, 106(12), 2000, pp. 1569-1569
Authors:
Meyer, L
Magierowska, M
Hubert, JB
Theodorou, I
van Rij, R
Prins, M
Husman, AMD
Coutinho, R
Schuitemaker, H
Citation: L. Meyer et al., CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients, AIDS, 13(5), 1999, pp. 624-626
Authors:
Prins, JM
Jurriaans, S
van Praag, RME
Blaak, H
van Rij, R
Schellekens, PTA
ten Berge, IJM
Yong, SL
Fox, CH
Roos, MTL
de Wolf, F
Goudsmit, J
Schuitemaker, H
Lange, JMA
Citation: Jm. Prins et al., Immune-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, 13(17), 1999, pp. 2405-2410
Authors:
Abebe, A
Demissie, D
Goudsmit, J
Brouwer, M
Kuiken, CL
Pollakis, G
Schuitemaker, H
Fontanet, AL
de Wit, TFR
Citation: A. Abebe et al., HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS, AIDS, 13(11), 1999, pp. 1305-1311
Citation: Na. Kootstra et H. Schuitemaker, Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages, VIROLOGY, 253(2), 1999, pp. 170-180
Authors:
Berkowitz, RD
van't Wout, AB
Kootstra, NA
Moreno, ME
Linquist-Stepps, VD
Bare, C
Stoddart, CA
Schuitemaker, H
McCune, JM
Citation: Rd. Berkowitz et al., R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus, J VIROLOGY, 73(9), 1999, pp. 7817-7822